Stammkötter Christian, Thümmler Laura, Korth Johannes, Marenbach Beate, Braß Peer, Horn Peter A, Lindemann Monika, Dittmer Ulf, Witzke Oliver, Rohn Hana, Krawczyk Adalbert
Department of Infectious Diseases, West German Centre of Infectious Diseases, University Medicine Essen, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.
Institute for Transfusion Medicine, University Hospital Essen, University Duisburg-Essen, 45147 Essen, Germany.
Infect Dis Rep. 2024 Jul 19;16(4):615-627. doi: 10.3390/idr16040047.
The emergence of SARS-CoV-2 in 2019 led to a global pandemic with a significant impact on healthcare systems. Healthcare workers were particularly vulnerable due to frequent contact with COVID-19 patients. Despite vaccination, they remained at higher risk as the vaccines provided limited protection against infection with viral variants, like Delta or Omicron BA.1 and BA.5. Three years after the onset of the pandemic, we evaluated SARS-CoV-2 infection frequencies among healthcare workers with varying levels of patient contact: high-risk (frequent COVID-19 patient contact), intermediate-risk (non-COVID-19 patient contact), and low-risk (no patient contact). We assessed their cellular and humoral immune responses based on their vaccination status and number of prior infections. SARS-CoV-2-specific antibodies were measured by immunoglobulin ELISA, and neutralizing antibody titers were determined against the viral variants D614G, Delta, and Omicron BA.1 and BA.5. Cellular immune responses were analyzed using an interferon-γ ELISpot. Notably, three years into the pandemic, healthcare workers in daily contact with COVID-19 patients did not have higher infection rates compared to healthcare workers with non-COVID-19 patient contact or no patient contact. Immune responses were similar across all groups, highlighting the effectiveness of vaccination and current hygiene standards in preventing virus transmission from patients to staff.
2019年严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的出现引发了一场全球大流行,对医疗系统产生了重大影响。医护人员由于频繁接触新型冠状病毒肺炎(COVID-19)患者而尤其易受感染。尽管接种了疫苗,但他们仍面临较高风险,因为这些疫苗对Delta或奥密克戎BA.1和BA.5等病毒变体感染的防护作用有限。在大流行开始三年后,我们评估了不同患者接触水平的医护人员中SARS-CoV-2的感染频率:高风险(频繁接触COVID-19患者)、中风险(接触非COVID-19患者)和低风险(无患者接触)。我们根据他们的疫苗接种状况和既往感染次数评估了他们的细胞免疫和体液免疫反应。通过免疫球蛋白酶联免疫吸附测定(ELISA)检测SARS-CoV-2特异性抗体,并测定针对病毒变体D614G、Delta以及奥密克戎BA.1和BA.5的中和抗体滴度。使用干扰素-γ酶联免疫斑点法(ELISpot)分析细胞免疫反应。值得注意的是,在大流行三年后,与接触非COVID-19患者或无患者接触的医护人员相比,每日接触COVID-19患者的医护人员感染率并没有更高。所有组的免疫反应相似,这突出了疫苗接种和当前卫生标准在预防病毒从患者传播给医护人员方面的有效性。